Anzeige
Mehr »
Login
Samstag, 19.09.2020 Börsentäglich über 12.000 News von 646 internationalen Medien
Warum Anleger jetzt noch schnell 100% verdienen können! Absolute Depot-Booster-Aktie!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Xconomy

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrBio Roundup: SeaGen Scores, Dyne's Debut, Microbiome Moves & More
DoDyne's Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
DoBIO Chief: "Reckless" Executive Order on Drug Prices Threatens Innovation
DoFinch Therapeutics Fetches $90M to Advance Microbiome Drug Pipeline
MiArrowhead Pharma Shares Soar on Early Liver Data for RNAi Drug
MiModerna CMO Talks COVID-19 Vaccine at Xcelerate Next Week
MiNeogene Therapeutics Grabs $110M to Tackle Solid Tumors With Cell Therapy
DiUnity Bio Restructuring Cuts 30% of Staff, Keeps Focus on Eye Drug
MoSeattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals
MoXconomy Awards On-Demand 'Meet the Finalists' Webcast Series Continues This Week
MoJoin Xconomy Next Week at the Virtual Xcelerate Keynote Series at Biotech Week Boston
MoGilead Adds "Cornerstone" Cancer Drug in $21B Immunomedics Buyout
11.09.Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More
10.09.Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans
10.09.Final Agenda Released for the Sept. 21 Xcelerate Keynote Series at Biotech Week Boston
10.09.Satsuma Pharma's Migraine Drug Fails to Beat Placebo in Phase 3 Test
10.09.Generate Bio Aims to Reveal Nature's Protein Secrets, Create New Drugs
09.09.Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
08.09.Grifols Moves Deeper Into Proteome R&D With $146M Deal for Alkahest
08.09.Xconomy Awards On-Demand 'Meet the Finalists' Webcast Series Launches This Week
05.09.FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
05.09.Q&A: BIO CEO Michelle McMurray-Heath Outlines Diversity Goals
04.09.AbbVie Strikes Deal for I-Mab Drug With a Potential Edge in CD47 Chase
04.09.Bio Roundup: Pharma M&A, AbbVie's Cancer Bet, Biofourmis Bucks & More
03.09.Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally